Jeffrey M Wilson1, Thomas A E Platts-Mills2. 1. Division of Allergy & Immunology, University of Virginia, Charlottesville, VA, 22908. 2. Division of Allergy & Immunology, University of Virginia, Charlottesville, VA, 22908. Electronic address: tap2z@virginia.edu.
Abstract
OBJECTIVE: To summarize the current understanding of anaphylaxis, with an emphasis on major findings that have been reported within the last 10 years. DATA SOURCES: Queries relating to anaphylaxis, immunoglobulin E (IgE), and mast cells were conducted with PubMed and Google Scholar, searching for primary articles and review papers. STUDY SELECTIONS: We focused on articles written in English and which were reported in major allergy and immunology journals. RESULTS: Anaphylaxis represents an extreme manifestation of a form of allergic immunity that appears to have evolved to protect against "toxic" threats that present at skin and mucosal barriers. The factors that have contributed to a rise in anaphylaxis are increasingly appreciated to relate to changes in hygiene and microbial ecology that have occurred with industrialization. Induction of allergen-specific IgG4 is often part of the allergic response and is associated with protection against anaphylaxis. The recognition of the α-Gal syndrome suggests that carbohydrates can be epitopes that are relevant to anaphylaxis and that IgE-mediated reactions do not always occur "immediately." CONCLUSION: Our understanding of anaphylaxis has advanced significantly over the past 10 years. It is anticipated that ongoing research will build on this foundation to further advance our knowledge of anaphylaxis and also translate into clinically meaningful therapies.
OBJECTIVE: To summarize the current understanding of anaphylaxis, with an emphasis on major findings that have been reported within the last 10 years. DATA SOURCES: Queries relating to anaphylaxis, immunoglobulin E (IgE), and mast cells were conducted with PubMed and Google Scholar, searching for primary articles and review papers. STUDY SELECTIONS: We focused on articles written in English and which were reported in major allergy and immunology journals. RESULTS:Anaphylaxis represents an extreme manifestation of a form of allergic immunity that appears to have evolved to protect against "toxic" threats that present at skin and mucosal barriers. The factors that have contributed to a rise in anaphylaxis are increasingly appreciated to relate to changes in hygiene and microbial ecology that have occurred with industrialization. Induction of allergen-specific IgG4 is often part of the allergic response and is associated with protection against anaphylaxis. The recognition of the α-Gal syndrome suggests that carbohydrates can be epitopes that are relevant to anaphylaxis and that IgE-mediated reactions do not always occur "immediately." CONCLUSION: Our understanding of anaphylaxis has advanced significantly over the past 10 years. It is anticipated that ongoing research will build on this foundation to further advance our knowledge of anaphylaxis and also translate into clinically meaningful therapies.
Authors: Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2014-03-20 Impact factor: 10.793
Authors: H Matsuda; N Watanabe; Y Kiso; S Hirota; H Ushio; Y Kannan; M Azuma; H Koyama; Y Kitamura Journal: J Immunol Date: 1990-01-01 Impact factor: 5.422
Authors: Azza Abdel-Gadir; Emmanuel Stephen-Victor; Georg K Gerber; Magali Noval Rivas; Sen Wang; Hani Harb; Leighanne Wang; Ning Li; Elena Crestani; Sara Spielman; William Secor; Heather Biehl; Nicholas DiBenedetto; Xiaoxi Dong; Dale T Umetsu; Lynn Bry; Rima Rachid; Talal A Chatila Journal: Nat Med Date: 2019-06-24 Impact factor: 53.440
Authors: Jeffrey M Wilson; Behnam Keshavarz; Hayley R James; Maya K C Retterer; Alexander J Schuyler; Alice Knoedler; Lisa J Workman; Lucy Ng'ang'a; Martha E Chico; Eva Rönmark; Peter W Heymann; Matthew S Perzanowski; Thomas A E Platts-Mills; Philip J Cooper Journal: J Allergy Clin Immunol Date: 2021-02-01 Impact factor: 10.793